首页> 外国专利> METHOD FOR DETERMINING AFFECTION RISK OF ARTERIOSCLEROTIC DISEASE OF DIABETIC PATIENT AND TEST AGENT THEREFOR

METHOD FOR DETERMINING AFFECTION RISK OF ARTERIOSCLEROTIC DISEASE OF DIABETIC PATIENT AND TEST AGENT THEREFOR

机译:确定糖尿病患者动脉硬化疾病的患病风险的方法及其试验试剂

摘要

PROBLEM TO BE SOLVED: To provide a gene and genetic polymorphism associated with occurrence risk of arteriosclerotic diseases of a diabetic patient, a method for determining the latent risk (affection risk) to develop arteriosclerotic diseases, especially atherosclerosis and myocardial infarction on individual diabetic patients based on the information on the gene, etc., especially the number of oxidation promoting alleles, and a reagent and a reagent kit useful for easily performing the method.SOLUTION: The level of the affection risk of arteriosclerotic diseases is determined by detecting (1) genetic polymorphism (GCLM C-588T) at position -588 of GCLM gene, (2) genetic polymorphism (MPO G-463A) at position -463 of MPO gene, (3) genetic polymorphism (PON 1 Gln192Arg) of PON1 gene and (4) genetic polymorphism (CYBA C242T) at position 242 of CYBA gene on a biospecimen of a diabetic patient, and determining the level based on the number of oxidation promoting alleles held by the polymorphisms.
机译:要解决的问题:要提供与糖尿病患者的动脉硬化疾病发生风险相关的基因和遗传多态性,一种确定潜在的风险(情感风险)​​的方法,以发展基于个体糖尿病患者的动脉硬化疾病,尤其是动脉粥样硬化和心肌梗塞解决方案:通过检测(1)来确定动脉硬化性疾病的患病风险水平:关于基因等信息的信息,尤其是促进氧化的等位基因的数目,以及有助于简便地执行该方法的试剂和试剂盒。在GCLM基因的-588位处有遗传多态性(GCLM C-588T),(2)在MPO基因的-463位处有遗传多态性(MPO G-463A),(3)PON1基因的遗传多态性(PON 1 Gln192Arg)和( 4)糖尿病患者生物标本中CYBA基因242位的遗传多态性(CYBA C242T),并根据多态性组织所持有的促进氧化的等位基因的数量确定其水平嘶嘶声。

著录项

  • 公开/公告号JP2011010618A

    专利类型

  • 公开/公告日2011-01-20

    原文格式PDF

  • 申请/专利权人 SIGNPOST CORP;

    申请/专利号JP20090159033

  • 发明设计人 KATAUE NAOTO;YAMAZAKI YOSHIMITSU;

    申请日2009-07-03

  • 分类号C12Q1/68;

  • 国家 JP

  • 入库时间 2022-08-21 18:24:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号